Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.65 USD | +2.61% | -3.62% | -19.39% |
Apr. 01 | Titan Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 26 | Titan Pharmaceuticals Regains Compliance With Nasdaq Listing Rule | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe1st Jan change | Capi. | |
---|---|---|
-19.39% | 5.93M | |
+32.05% | 694B | |
+29.39% | 593B | |
-1.81% | 371B | |
+19.94% | 331B | |
+6.71% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+7.82% | 169B |
- Stock Market
- Equities
- TTNP Stock
- News Titan Pharmaceuticals, Inc.
- Transcript : Titan Pharmaceuticals, Inc., Q3 2018 Earnings Call, Nov 14, 2018